Funding for this research was provided by:
Universitätsklinikum Freiburg
Article History
Received: 18 July 2022
Accepted: 30 August 2022
First Online: 13 September 2022
Declarations
:
: DLS reports lecture fees from Abiomed, OrionPharma, GetingeGroup, Medtronic, AstraZeneca, and Dahlhausen all of which are outside the submitted work. XB reports lecture fees from Amomed, outside of the submitted work. The other authors declare that they have no competing interests.
: Not applicable.